NAT2 genotype and acetylator status on tuberculosis patients who received antituberculosis

Funding period : 2015- Deactivate

Abstrak

Related Research

Analysing GSTM1 Genotype on Tuberculosis Patients Received Category I of Antituberculosis

2016-
Inactive

Identification of PXR, NAT2*6 Genotype and Hepatotoxic Status on Tuberculosis Patients Received Antituberculosis

2017-
Inactive

In Vivo Study: The effect of Isoniazid and Rifampicin on Liver Histopathology, Serum ASt and ALT level

2018-
Inactive